HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Schwarcz Selected Research

Ro 61-8048

11/2013Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.
7/2005Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Schwarcz Research Topics

Disease

25Schizophrenia (Dementia Praecox)
01/2021 - 08/2003
13Neurodegenerative Diseases (Neurodegenerative Disease)
05/2019 - 01/2003
12Huntington Disease (Huntington's Disease)
01/2019 - 01/2003
8Cognitive Dysfunction
06/2020 - 05/2012
7Mental Disorders (Mental Disorder)
01/2021 - 08/2004
4Infections
01/2017 - 11/2012
3Alzheimer Disease (Alzheimer's Disease)
01/2019 - 07/2007
3Brain Diseases (Brain Disorder)
01/2017 - 12/2008
3Nervous System Diseases (Neurological Disorders)
01/2017 - 02/2012
2Parkinson Disease (Parkinson's Disease)
01/2019 - 07/2005
2Memory Disorders (Memory Loss)
01/2019 - 07/2014
2Neurodevelopmental Disorders
01/2019 - 01/2019
2Inflammation (Inflammations)
10/2017 - 11/2016
2Dyskinesias (Dyskinesia)
01/2008 - 07/2005
2Seizures (Absence Seizure)
01/2008 - 09/2002
2Epilepsy (Aura)
11/2005 - 07/2005
1Congenital Abnormalities (Deformity)
04/2022
1Vision Disorders (Hemeralopia)
01/2020
1Neuroinflammatory Diseases
01/2019
1Depressive Disorder (Melancholia)
01/2018
1Psychotic Disorders (Schizoaffective Disorder)
11/2017
1Hyperalgesia
10/2017
1Necrosis
10/2016
1Cicatrix (Scar)
01/2016
1Treatment-Resistant Depressive Disorder
10/2015
1HIV Infections (HIV Infection)
08/2015
1Central Nervous System Diseases (CNS Diseases)
08/2015
1Substance-Related Disorders (Drug Abuse)
11/2013
1Cellulitis
11/2012
1Abscess
11/2012
1Syndrome (Syndromes)
04/2012
1Partial Epilepsies (Epilepsy, Partial)
01/2008

Drug/Important Bio-Agent (IBA)

28Kynurenic Acid (Kynurenate)IBA
01/2021 - 08/2003
27KynurenineIBA
01/2021 - 01/2006
19Tryptophan (L-Tryptophan)FDA Link
01/2021 - 03/2008
9Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA
01/2019 - 07/2005
8Quinolinic AcidIBA
01/2020 - 01/2003
8N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2017 - 01/2006
6EnzymesIBA
01/2019 - 12/2008
6polyglutamineIBA
04/2012 - 01/2003
53-hydroxykynurenineIBA
11/2017 - 01/2003
5Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2016 - 08/2003
4Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2017 - 08/2003
4N-Methylaspartate (NMDA)IBA
03/2010 - 08/2003
3Acetylcholine (Acetylcholine Chloride)FDA Link
11/2017 - 11/2011
3Huntingtin ProteinIBA
04/2012 - 12/2004
3Proteins (Proteins, Gene)FDA Link
02/2010 - 01/2003
2Dronabinol (THC)FDA LinkGeneric
01/2020 - 11/2013
2kynurenine-oxoglutarate transaminaseIBA
01/2019 - 03/2014
2ProdrugsIBA
01/2019 - 09/2002
2CytokinesIBA
01/2018 - 10/2016
2Serotonin (5 Hydroxytryptamine)IBA
01/2017 - 08/2015
2Biomarkers (Surrogate Marker)IBA
08/2015 - 07/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
07/2014 - 08/2010
2Ro 61-8048IBA
11/2013 - 07/2005
2Pharmaceutical PreparationsIBA
11/2013 - 07/2007
2NeurotoxinsIBA
02/2012 - 07/2006
2alpha7 Nicotinic Acetylcholine ReceptorIBA
03/2010 - 04/2005
2Levodopa (L Dopa)FDA LinkGeneric
01/2008 - 07/2005
1RestylaneIBA
04/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2021
1Neuroprotective AgentsIBA
01/2020
1PlasticsIBA
01/2020
1EndocannabinoidsIBA
05/2019
1Poly I-CIBA
01/2019
1BFF-816IBA
01/2019
1Essential Amino AcidsIBA
01/2018
1Glutamic Acid (Glutamate)FDA Link
01/2018
1Formaldehyde (Formol)FDA Link
10/2017
1CarrageenanIBA
10/2017
1Gabapentin (Neurontin)FDA LinkGeneric
10/2017
1Dizocilpine Maleate (Dizocilpine)IBA
10/2017
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2016
1Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA
11/2016
1InterferonsIBA
10/2016
1KetamineFDA LinkGeneric
10/2015
1gamma-Aminobutyric Acid (GABA)IBA
07/2014
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
03/2014
1CannabinoidsIBA
11/2013
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
11/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2012
1Antipsychotic Agents (Antipsychotics)IBA
04/2012
1IronIBA
02/2012
1Messenger RNA (mRNA)IBA
07/2011
1Cholinergic Agents (Cholinergics)IBA
01/2010
1Transaminases (Aminotransferases)IBA
12/2008
1IsoenzymesIBA
12/2008
1Histone Deacetylase InhibitorsIBA
03/2008
1Histone Deacetylases (Histone Deacetylase)IBA
03/2008
1SilverIBA
01/2008
1LigandsIBA
07/2007
1Galantamine (Galanthamine)FDA LinkGeneric
07/2007

Therapy/Procedure

3Therapeutics
01/2019 - 11/2005
1Operative Surgical Procedures
01/2020
1Ligation
10/2017
1Blepharoplasty
01/2016
1Traction
01/2016
1Highly Active Antiretroviral Therapy (HAART)
08/2015
1Self Administration (Administration, Self)
11/2013
1Hair Removal (Depilation)
11/2012